Criticism prompts Harbin Pharma to address plant's pollution problems
This article was originally published in Scrip
Executive Summary
The major Chinese pharma group Harbin Pharmaceutical has been harshly criticised for pollution issuing from its active pharmaceutical ingredient plant in Harbin, which it is now moving to rectify following negative nationwide media coverage.